Dexamethasone-Induced Sarcopenia and Physical Frailty in Children With Acute Lymphoblastic Leukemia: Protocol for a Prospective Cohort Study

BACKGROUND: During treatment for pediatric acute lymphoblastic leukemia (ALL), children receive high doses of dexamethasone for its apoptotic effect on leukemia cells; however, muscle atrophy is a well-known serious side effect. Muscle atrophy (loss of muscle mass) accompanied by a decreased muscle...

Descripción completa

Detalles Bibliográficos
Autores principales: Verwaaijen, Emma Jacobine, van Hulst, Annelienke, Fiocco, Marta, Hartman, Annelies, Grootenhuis, Martha, Pluijm, Saskia, Pieters, Rob, van den Akker, Erica, van den Heuvel-Eibrink, Marry M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039819/
https://www.ncbi.nlm.nih.gov/pubmed/35403603
http://dx.doi.org/10.2196/33517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039819/
https://www.ncbi.nlm.nih.gov/pubmed/35403603
http://dx.doi.org/10.2196/33517

Ejemplares similares